Pfizer, AstraZeneca COVID jabs ‘highly effective’ against India variant, study shows | Euronews

Public Health England (PHE) said on Sunday that the Pfizer vaccine was 88 per cent effective against symptomatic disease from the Indian variant — named B.1.617.2 — two weeks after the second dose.

Source: Pfizer, AstraZeneca COVID jabs ‘highly effective’ against India variant, study shows | Euronews